Extranodal NK/T-cell lymphoma, nasal type: Study of clinicopathologic and prognosis factors in a series of 78 cases from Peru

Applied Immunohistochemistry and Molecular Morphology

Volumn 15, Issue 1, 2007, Pages 38-44

  Barrionuevo, Carlos ^a   Zaharia, Mayer ^a   Martinez, Marco T ^a   Taxa, Luis ^a   Misad, Oscar ^a   Moscol, Alfredo ^a   Sarria, Gustavo ^a   Guerrero, Ivonne ^b   Casanova, Luis ^a   Flores, Claudio ^b   Zevallos Giampietri, Eduardo Alfredo ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES NEOPLÁSICAS   (Peru)

^b Maes Heller Cancer Research Centre   (Peru)

Author keywords

Differential diagnosis; EBV; Extranodal NK T cell lymphoma; Grading; Immunohistochemistry; Lymphoma; Nasal lymphoma; Nasal neoplasm; PCR; Prognosis; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CD2 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOMA CELL; MAJOR CLINICAL STUDY; MALE; METASTASIS; NATURAL KILLER CELL; NOSE CARCINOMA; NOSE OBSTRUCTION; OVERALL SURVIVAL; PERU; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; T CELL LYMPHOMA; VIRUS TYPING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; NOSE NEOPLASMS; PERU; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 34247578752     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/01.pai.0000205062.27174.56     Document Type: Article

References (35)

1. Chan JKC. CD56-positive putative natural killer (NK) cell lymphomas: nasal type, blastoid, and leukemic forms. Adv Anat Pathol. 1997;4:163-172.
2. Chan JKC, Ng CS, Lau WH, et al. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol. 1987;11:418-429.
3. Ho FCS, Choy D, Loke SL, et al. Polymorphic reticulosis and conventional lymphomas of the nose and aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic study of 16 cases. Hum Pathol. 1990;21:1041-1050.
4. Ishii Y, Yamanaka N, Ogawa K, et al. Nasal T-cell lymphoma as a type of so called "lethal midline granuloma." Cancer. 1982;50:2336-2344.
5. Itami J, Itami M, Mikata A, et al. Non-Hodgkińs lymphoma confined to the nasal cavity: its relationship to polymorphic reticulosis and results of radiation therapy. Int J Radiat Oncol Biol Phys. 1991;20:797-802.
6. Liang R, Todd D, Chan TK, et al. Nasal lymphoma: a retrospective analysis of 60 cases. Cancer. 1990;66:2205-2209.
7. Liang R, Todd D, Chan TK, et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol. 1995;13:666-670.
8. Jaffe ES. Pathology of the Lymph Nodes and Related Organs. 2nd ed. Philadelphia: WB Saunders; 1994.
9. Guerrero I, Franklin JL, Naresh KN, et al. P53 expression, BCL2 expression and EBV association in Peruvian nasal lymphomas. Blood. 1994;84:522.
10. Misad O, Solidoro A, Quiroz L, et al. An overview of lymphoreticular malignancies in Peru. Prog Cancer Res Ther. 1984;27:85-97.
11. Solidoro A, Misad O. Linfoma en el Perú y el mundo: Un estudio multinacional de las neoplasias de sistema linfático. Acta Cancerol. 1988;XIX:15-26.
12. Arber DA, Weiss LM, Albújar PF, et al. Nasal lymphomas in Perú: high incidence of the T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol. 1993;17:392-399.
13. Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell in patients with lethal midline granuloma. Lancet. 1990;335:128-130.
14. Jones JF, Shuring S, Abramousky C, et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med. 1988;318:733-744.
15. Medeiros LJ, Jaffe ES, Chen YY, et al. Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. Am J Surg Pathol. 1992;16:439-447.
16. Su IJ, Hsieh HC, Lin KH, et al. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood. 1991;77:799-808.
17. Su IJ, Lin KH, Chen CJ, et al. Epstein-Barr virus-associated T-cell lymphoma of activated CD8 phenotype. Cancer. 1990;66:2557-2562.
18. Telenti A. PCR detection and typing of Epstein-Barr virus. In: Persing DH, Smith TF, Tenover FC, et al. eds. Diagnostic Molecular Microbiology. Washington, DC: American Society for Microbiology; 1993:344-349.
19. Weiss LM, Gaffey MJ, Chen Y-Y, et al. Frequency of Epstein-Barr viral DNA in "Western" sinonasal and Waldeyeŕs ring non-Hodgkińs lymphomas. Am J Surg Pathol. 1992;16:156-162.
20. Lipford EH, Margolick JB, Longo DA, et al. Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood. 1988;72:1674-1681.
21. Jaffe ES, Chan JKC, Su IJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/Natural Killer cell lymphomas: definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20:103-111.
22. Bobrow MN, Harris TD, Shaughnessy KS, et al. Catalyzed reporter deposition, a novel method of signal amplification: application to immunoassays. J Immunol Methods. 1989;125:279-285.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual 1. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
24. Chiang AK, Chan AC, Srivastava G, et al. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage. Int J Cancer. 1997;73:332-338.
25. Ng CS, Lo ST, Chan JK, et al. CD56+ putative natural killer cell lymphomas: production of cytolytic effectors and related proteins mediating tumor cell apoptosis? Hum Pathol. 1997;28:1276-1282.
26. Ng CS, Lo ST, Chan JK. Peripheral T and putative natural killer cell lymphomas commonly coexpress CD95 and CD95 ligand. Hum Pathol. 1999;30:48-53.
27. Aozasa K, Yang WJ, Lee YB, et al. Lethal midline granuloma in Seoul (Korea) and Shanghai (China). Int J Cancer. 1992;52:673-674.
28. Chan JKC, Jaffe ES, Ralfkiaer E. Extranodal NK/T-cell lymphoma, nasal type. In: Jaffe ES, Harris NL, Stein H, et al. eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001: 204-207.
29. Borics B, Henning L, Laeng RH, et al. Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkińs lymphoma of the midline granuloma type. Blood. 1993;82:858-864.
30. Tomita Y, Ohsawa M, Mishiro Y, et al. The presence and subtype of Epstein-Barr virus in B and T cell lymphomas of the sino-nasal region from the Osaka and Okinawa districts of Japan. Lab Invest. 1995;73:190-196.
31. Tomita Y, Ohsawa M, Qiu K, et al. Epstein-Barr virus in lymphoproliferative diseases in the sino-nasal region: close association with CD56+ immunophenotype and polymorphic reticulosis morphology. Int J Cancer. 1997;70:90-113.
32. Kwong YL, Chan AC, Liang R, et al. CD56+ NK lymphomas: clinicopathological features and prognosis. Br J Haematol. 1997;97:821-829.
33. Kuo TT, Shih LY, Tsang NM. Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities. Int J Surg Pathol. 2004;12:375-387.
34. Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol. 1998;16:70-77.
35. Takahara M, Kishibe K, Bandoh N, et al. P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan. Hum Pathol. 2004;35:86-95.